The role of soluble cell adhesion molecules in patients with suspected deep vein thrombosis

Blood Coagulation and Fibrinolysis

Volumn 14, Issue 7, 2003, Pages 653-657

  Bucek, Robert A ^a   Reiter, Markus ^a   Quehenberger, Peter ^b   Minar, Erich ^a   Baghestanian, Mehrdad ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cell adhesion molecules; Deep vein thrombosis; Diagnostic process; Inflammation

Indexed keywords

CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; PADGEM PROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIAGNOSTIC PROCEDURE; ECHOGRAPHY; ENDOTHELIUM CELL; FEMALE; HUMAN; LEUKOCYTE ACTIVATION; MALE; PHLEBOGRAPHY; PRIORITY JOURNAL; SYMPTOMATOLOGY; THROMBOCYTE ACTIVATION; THROMBUS;

ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; E-SELECTIN; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; P-SELECTIN; PHLEBOGRAPHY; SOLUBILITY; ULTRASONOGRAPHY, DOPPLER, DUPLEX; VASCULAR CELL ADHESION MOLECULE-1; VENOUS THROMBOSIS;

EID: 0142187194     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200310000-00006     Document Type: Article

References (28)

1. Nordström M, Lindblad B. Bergqvist D, Kjellström T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 1992; 232:155-160.
2. Kahn SR. The clinical diagnosis of deep venous thrombosis: integrating incidence, risk factors, and symptoms and signs. Arch Intern Med 1998; 158:2315-2323.
3. Ruckley CV. Socioeconomic impact of chronic venous insufficiency and leg ulcers. Angiology 1997; 48:67-69.
4. Stewart G. Neutrophils and deep venous thrombosis. Haemostasis 1993; 23:127-140.
5. Wakefield TW, Greenfield LJ, Rolfe MW, DeLucia A 3rd, Strieter RM, Abrams GD, et al. Inflammation and procoagulant mediator interactions in an experimental baboon model of venous thrombosis. Thromb Haemost 1993; 69:164-172.
6. Wakefield TW, Strieter RM, Prince MR, Downing LJ, Greenfield LJ. Pathogenesis of venous thrombosis: a new insight. Cardiovasc Surg 1997; 5:6-15.
7. Wakefield TW, Strieter RM, Schaub R, Myers DD, Prince MR, Wrobleski SK, et al. Venous thrombosis prophylaxis by inflammatory inhibition without anticoagulation therapy. J Vasc Surg 2000; 31:309-324.
8. Cowley HC, Heney D, Gearing AJ, Hemingway I, Webster NR. Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndrome: a prospective cohort study. Crit Care Med 1994; 22:651-657.
9. Downing LJ, Strieter RM, Kadell AM, Wilke Ca, Brown SL, Wrobleski SR, et al. Neutrophils are the initial cell type identified in deep venous thrombosis induced vein wall inflammation. ASAIO J 1996; 42: M677-M682.
10. Downing LJ, Wakefield TW, Strieter RM, Prince MR, Londy FJ, Fowlkes JB, et al. Anti-P-selectin antibody decreases inflammation and thrombus formation in venous thrombosis. J Vasc Surg 1 997; 25:816-827.
11. Cummings CJ, Sessler CN, Beall D, Fisher BJ, Best AM, Fowler AA 3rd. Soluble E-selectin levels in sepsis and critical illness: correlation with infection and hemodynamic dysfunction. Am J Respir Crit Care Med 1997; 156:431-437.
12. Bucek RA, Reiter M, Quehenberger P, Minar E. C-reactive protein in the diagnosis of deep vein thrombosis. Br J Haematol 2002; 119:385-389.
13. Roumen-Klappe EM, den Heijer M, van Uum SH, van der Ven-Jongekrijg J, van der Graaf F, Wollersheim H. Inflammatory response in the acute phase of deep vein thrombosis. J Vasc Surg 2002; 35:701-706.
14. Smith A, Quarmby JW, Collins M, Lockhart SM, Burnand KG. Changes in the levels of soluble adhesion molecules and coagulation factors in patients with deep vein thrombosis. Thromb Haemost 1999; 82: 1593-1599.
15. Hackman A, Abe Y, Insull W, Pownall H, Smith L, Dunn K, et al. Levels of soluble adhesion molecules in patients with dyslipidemia. Circulation 1996; 93:1334-1338.
16. Blann AD, Lip GYH. Hypothesis: is soluble P-selectin a new marker of platelet activation? Atherosclerosis 1997; 128:135-138.
17. Wells PS, Anderson DR, Bormanis J, Guy F, Mitchell M, Gray L, et al. Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet 1997; 350:1795-1798.
18. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994; 76:301-314.
19. Osborn L, Hession C, Tizard R, Vassallo C, Luhowskyj S, Chi-Rosso G, et al. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 1989; 59:1203-1211.
20. Marui N, Offermann MK, Swerlick R, Kunsch C, Rosen CA, Ahmad M, et al. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant sensitive mechanism in human vascular endothelial cells. J Clin Invest 1993; 92:1866-1874.
21. Ahmad M, Marui N, Alexandr RW, Medford RM. Cell type-specific transactivation of the VCAM-1 promoter through an NFkappa B enahncer motif. J Biol Chem 1 995; 270:8976-8983.
22. Pigott R, Dillon LP, Hemingway IH, Gearing AJ. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun 1992; 187:584-589.
23. Nash GB. Adhesion between neutrophils and platelets: a modulator of thrombotic and inflammatory events? Thromb Res 1994; 74(suppl 1): S3-S11.
24. Wyble CW, Hynes KL, Kuchibhotla J, Marcus BC, Hallahan D, Gewertz BL. TNF-alpha and IL-1 upregulate membrane-bound and soluble E-selectin through a common pathway. J Surg Res 1997; 73:107-112.
25. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 1986; 137: 245-254.
26. Pober JS, Gimbrone MA Jr, Lapierre LA, Mendrick DL, Fiers W, Rothlein R, et al. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol 1986; 137:1893-1896.
27. Blann AD, Noteboom WM, Rosendall FR. Increased soluble P-selectin levels following deep venous thrombosis: cause or effect? Br J Haematol 2000; 108:191-193.
28. Quarmby J, Smith A, Collins M, Cederholm-Williams S, Burnand K. A model of in vivo human venous thrombosis that confirms changes in the release of specific soluble cell adhesion molecules in experimental venous thrombogenesis. J Vasc Surg 1999; 30:139-147.